Abstract
Mitonafide (4-nitro-benzoisoquinolinedione) and a number of structural analogs were synthesized and studied in order to determine the structural requirements for inhibition of leishmanial nuclear and kinetoplast topoisomerase II and human topoisomerase II. The structure-activity relationship studies with the mitonafide analogs demonstrated that there was selective targeting of leishmanial nuclear topoisomerase II and human topoisomerase II and differential targeting of kinetoplast over nuclear topoisomerase II in the parasite. Mitonafide analogs appeared to have multiple mechanisms of action leading to death of leishmanias, but several compounds that affected kinetoplast but not nuclear topoisomerase II were not cytotoxic as determined by short-term assays. These studies provide new insight into the differential sensitivities of leishmanial nuclear and kinetoplast topoisomerase II to topoisomerase II-targeting drugs.
Full Text
The Full Text of this article is available as a PDF (209.4 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berens R. L., Brun R., Krassner S. M. A simple monophasic medium for axenic culture of hemoflagellates. J Parasitol. 1976 Jun;62(3):360–365. [PubMed] [Google Scholar]
- Braña M. F., Castellano J. M., Roldán C. M., Santos A., Vázquez D., Jiménez A. Synthesis and mode(s) of action of a new series of imide derivatives of 3-nitro-1,8 naphthalic acid. Cancer Chemother Pharmacol. 1980;4(1):61–66. doi: 10.1007/BF00255461. [DOI] [PubMed] [Google Scholar]
- Chakraborty A. K., Majumder H. K. Decatenation of kinetoplast DNA by an ATP-dependent DNA topoisomerase from the kinetoplast hemoflagellate Leishmania donovani. Mol Biochem Parasitol. 1987 Dec;26(3):215–224. doi: 10.1016/0166-6851(87)90074-0. [DOI] [PubMed] [Google Scholar]
- Corbett A. H., Osheroff N. When good enzymes go bad: conversion of topoisomerase II to a cellular toxin by antineoplastic drugs. Chem Res Toxicol. 1993 Sep-Oct;6(5):585–597. doi: 10.1021/tx00035a001. [DOI] [PubMed] [Google Scholar]
- Croft S. L., Hogg J. Limited activity of bacterial DNA topoisomerase II inhibitors against Leishmania donovani and Trypanosoma cruzi amastigotes in vitro. Trans R Soc Trop Med Hyg. 1988;82(6):856–856. doi: 10.1016/0035-9203(88)90017-x. [DOI] [PubMed] [Google Scholar]
- Drlica K., Franco R. J. Inhibitors of DNA topoisomerases. Biochemistry. 1988 Apr 5;27(7):2253–2259. doi: 10.1021/bi00407a001. [DOI] [PubMed] [Google Scholar]
- Englund P. T. The replication of kinetoplast DNA networks in Crithidia fasciculata. Cell. 1978 May;14(1):157–168. doi: 10.1016/0092-8674(78)90310-0. [DOI] [PubMed] [Google Scholar]
- Figgitt D., Denny W., Chavalitshewinkoon P., Wilairat P., Ralph R. In vitro study of anticancer acridines as potential antitrypanosomal and antimalarial agents. Antimicrob Agents Chemother. 1992 Aug;36(8):1644–1647. doi: 10.1128/aac.36.8.1644. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hsiang Y. H., Jiang J. B., Liu L. F. Topoisomerase II-mediated DNA cleavage by amonafide and its structural analogs. Mol Pharmacol. 1989 Sep;36(3):371–376. [PubMed] [Google Scholar]
- Kallinikova V. D. The kinetoplast as a cell organelle. Int Rev Cytol. 1981;69:105–156. doi: 10.1016/s0074-7696(08)62321-9. [DOI] [PubMed] [Google Scholar]
- Liu L. F. DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem. 1989;58:351–375. doi: 10.1146/annurev.bi.58.070189.002031. [DOI] [PubMed] [Google Scholar]
- Mather M. W. Base composition-independent hybridization in dried agarose gels: screening and recovery for cloning of genomic DNA fragments. Biotechniques. 1988 May;6(5):444–447. [PubMed] [Google Scholar]
- Mauël J., Denny W., Gamage S., Ransijn A., Wojcik S., Figgitt D., Ralph R. 9-Anilinoacridines as potential antileishmanial agents. Antimicrob Agents Chemother. 1993 May;37(5):991–996. doi: 10.1128/aac.37.5.991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pearson R. D., Manian A. A., Hall D., Harcus J. L., Hewlett E. L. Antileishmanial activity of chlorpromazine. Antimicrob Agents Chemother. 1984 May;25(5):571–574. doi: 10.1128/aac.25.5.571. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pearson R. D., Manian A. A., Harcus J. L., Hall D., Hewlett E. L. Lethal effect of phenothiazine neuroleptics on the pathogenic protozoan Leishmania donovani. Science. 1982 Jul 23;217(4557):369–371. doi: 10.1126/science.6124040. [DOI] [PubMed] [Google Scholar]
- Pearson R. D., Steigbigel R. T. Mechanism of lethal effect of human serum upon Leishmania donovani. J Immunol. 1980 Nov;125(5):2195–2201. [PubMed] [Google Scholar]
- Rowe T. C., Chen G. L., Hsiang Y. H., Liu L. F. DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II. Cancer Res. 1986 Apr;46(4 Pt 2):2021–2026. [PubMed] [Google Scholar]
- Shapiro T. A., Englund P. T. Selective cleavage of kinetoplast DNA minicircles promoted by antitrypanosomal drugs. Proc Natl Acad Sci U S A. 1990 Feb;87(3):950–954. doi: 10.1073/pnas.87.3.950. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shapiro T. A., Klein V. A., Englund P. T. Drug-promoted cleavage of kinetoplast DNA minicircles. Evidence for type II topoisomerase activity in trypanosome mitochondria. J Biol Chem. 1989 Mar 5;264(7):4173–4178. [PubMed] [Google Scholar]
- Shen L. L., Kohlbrenner W. E., Weigl D., Baranowski J. Mechanism of quinolone inhibition of DNA gyrase. Appearance of unique norfloxacin binding sites in enzyme-DNA complexes. J Biol Chem. 1989 Feb 15;264(5):2973–2978. [PubMed] [Google Scholar]
- Werbovetz K. A., Lehnert E. K., Macdonald T. L., Pearson R. D. Cytotoxicity of acridine compounds for Leishmania promastigotes in vitro. Antimicrob Agents Chemother. 1992 Feb;36(2):495–497. doi: 10.1128/aac.36.2.495. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Werbovetz K. A., Spoors P. G., Pearson R. D., Macdonald T. L. Cleavable complex formation in Leishmania chagasi treated with anilinoacridines. Mol Biochem Parasitol. 1994 May;65(1):1–10. doi: 10.1016/0166-6851(94)90110-4. [DOI] [PubMed] [Google Scholar]